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We report 4 bloodstream infections associated with CC9
agr type II Staphylococcus aureus in individuals without
animal exposure. We demonstrate, by microarray analysis,
the presence of egc cluster, fnbA, cap operon, lukS, set2,
set12, splE, splD, sak, epiD, and can, genomic features asso-
ciated with a high virulence potential in humans.
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Staphylococcus aureus is a leading cause of bloodstream infec-
tion (BSI), associated with high levels of morbidity and mor-
tality. Over the past 50 years, S. aureus has undergone changes
in its genetic makeup, resulting in the emergence of clones
that are successfully transmitted and cause disease in hospital
and community settings. Staphylococcus aureus also colonizes
and infects animals, particularly livestock. Staphylococcus
aureus belonging to clonal complexes 398 (CC398) and CC9
is associated worldwide with livestock, their human contacts,
and food products. To date, human infections with livestock-
associated (LA) S. aureus isolates have generally occurred in
farmers or veterinary surgeons [1].
However, in France [2] and worldwide [3], CC398 strains
have recently emerged in patients without animal exposure, in
whom they have caused BSI. Likewise, during an annual pro-
spective, longitudinal BSI survey initiated in 2002 in France [4],
we identiﬁed, in 2011 and 2012, the 4 ﬁrst cases of BSI due to
CC9 S. aureus, in patients without animal exposure. We docu-
ment this emergence by reporting the clinical context and de-
termining the genomic content of these CC9 isolates.
METHODS
BSI Epidemiologic Survey Method
A BSI surveillance program and a microbiologic study of S.
aureus isolates from BSI cases have been conducted since
2002, in the central region of France (2.5 million inhabitants).
The methods, study design, and data for the years 2000–2008
have been reported elsewhere [4].
Microbiologic Methods
BSI-associated S. aureus isolates were collected during each
survey period and sent to a central laboratory. Antimicrobial
drug susceptibility testing was performed by the disk diffusion
method (Bio-Rad). The mecA and cfr genes were detected by
polymerase chain reaction (PCR) [4, 5]. DNA macrorestriction
and pulsed-ﬁeld gel electrophoresis (PFGE) were used for
typing [4]. PCR targeting sau1-hsdS1 was used for the detec-
tion of CC398 isolates [6]. For multilocus sequence typing
(MLST), S. aureus isolates were analyzed as previously de-
scribed [4]. Spa types were determined for all isolates as previ-
ously described and were assigned through the database www.
ridom.de/spaserver [4]. Typing for agr was performed and iso-
lates were classiﬁed as agr types I to IV [4]. PCR was per-
formed to detect virulence genes (lukS-PV, lukF-PV, tst, eta,
etb, and the genes encoding enterotoxins A, B, C, D, E, G, H,
I, J, K, L, M, N, O, P, Q, U, and R) [7]. In DNA microarray
experiments, isolates were studied with a previously described
oligonucleotide microarray [4].
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French healthcare recommendations. Ethics approval for these
surveillance studies was obtained at the national level from the
Réseau Alerte Investigation Surveillance des Infections
Nosocomiales.
RESULTS
During the 2007–2012 period, 723 cases of S. aureus BSI were
diagnosed in our network and 685 (94.7%) S. aureus isolates
were available for analysis. SmaI PFGE patterns were obtained
for all but 27 isolates (3.9%), which were assigned to CC398
by MLST. During the 2011 and 2012 survey periods, 4 isolates
presented a similar PFGE pattern that had never been ob-
served before, and were thus subjected to MLST; all were as-
signed to CC9.
The 4 CC9-associated BSI cases were diagnosed at different
hospitals, some distance apart and with no epidemiologic link.
Two cases were genitourinary-associated BSI: a case of
urinary-associated BSI in an 85-year-old man and a case asso-
ciated with orchitis in a 58-year-old man with diabetes melli-
tus. A third BSI with no recognized portal of entry was
identiﬁed in an 87-year-old man. The remaining case was a
central venous catheter–associated infection in a 69-year-old
man. An examination of patient histories and epidemiologic
investigation revealed an absence of exposure to animal for all
these patients.
The CC9 isolates were all of agr type II. Three of the 4 CC9
isolates had the same resistance pattern (only EryR), whereas
the fourth was susceptible to all antibiotics. mecA and cfr were
not detected. Spa typing identiﬁed 3 related spa types: t587 (2
isolates), t1939 (1 isolate), a spa type assigned to a CC9 pig-
borne isolate [8], and t8666 (1 isolate). The 4 isolates had se-
quences corresponding to the genes encoding the enterotoxins
G, I, M, N, O, and U, known as the egc cluster. By contrast,
they had no sequences corresponding to lukS-PV and lukF-
PV, encoding Panton-Valentine leukocidin; tst, encoding toxic
shock syndrome toxin 1; the eta and etb genes, encoding exfo-
liatins A and B, respectively; or the genes encoding enterotox-
ins A, B, C, D, E, H, J, K, L, P, Q, and R.
Given the similar PFGE pattern obtained, microarray analy-
sis was carried out for 2 of the 4 CC9 isolates. Microarray data
were compared with those for 3 reference strains (USA300/
CC8, COL/ST250, and RF122/ST151) and 8 previously charac-
terized CC398 isolates [9]. Like the reference strains studied
(Figure 1), but unlike CC398 isolates, the BSI-CC9 isolates
had sequences corresponding to genes encoding many major
staphylococcal virulence factors, some associated with various
pathogenicity islands and prophages: FnbA adhesin, capsule
operon, leukocidin S, enterotoxins A, B, C3, G, H, I, K, L, M,
N, O, and P, superantigens SET2 and SET12, proteases SplE
and SplD, and staphylokinase. They also contained the
Figure 1. Microarray data for virulence factors, obtained with the 2
CC9 isolates, 8 CC398 isolates, and 3 reference strains (RF122, COL, and
USA300). Abbreviation: S. aureus, Staphylococcus aureus.
e84 • CID 2013:56 (15 April) • BRIEF REPORT
lantibiotic epidermin/gallidermin gene epiD typically harbored
by virulent isolates and had a complete type I restriction-mod-
iﬁcation system (hsdS-hsdR), which plays a key role in the lim-
itation of horizontal gene transfer. Nevertheless, the CC9
isolates had 2 major characteristics in common with CC398
isolates: they harbored the cna gene encoding the collagen-
adhesin associated with colonizing strains and involved in the
pathogenesis of osteomyelitis and infectious arthritis, and the
gene encoding the chemotaxis inhibitory protein CHIPS,
which protects S. aureus from human innate immunity [10].
DISCUSSION
In an LA environment, CC9 methicillin-resistant S. aureus
(MRSA) strains easily colonize and infect humans [1, 11]. But so
far, in an animal-free environment, CC9 is a minor lineage asso-
ciated with scarce nasal carriage [12, 13] and bloodstream infec-
tions in human [14, 15]. In a context of increasing incidence of
S. aureus BSI [16], and following the recent emergence of a
new CC398 methicillin-susceptible S. aureus (MSSA) lineage,
non-LA CC398, causing severe infections in patients without
exposure to animals [2, 3], we report the emergence of a second
S. aureus MSSA lineage, non-LA CC9, responsible for severe
human BSI in an animal-free environment.
CC9 LA isolates are of agr type II and have an egc cluster,
but are genetically diverse, as shown by their spa types (mostly
t899, t1430, and t337), antibiotic susceptibility patterns and, for
MRSA, their SCCmec elements [17]. Our CC9 isolates were also
of agr type II and harbored the egc cluster, but they remained
susceptible to most currently used antibiotics. More remarkably,
our non-LA CC9 isolates had several characteristics in common
with the successful emerging non-LA CC398 strains. First, 3 of
the 4 CC9 isolates had the same resistance pattern (only EryR
MSSA). Second, they had the human-speciﬁc chp gene, a gene
of phage origin typically harbored by virulent S. aureus respon-
sible for severe human infections, and recently identiﬁed as a
marker of a beta-converting prophage carrying an immune
evasion cluster associated with non-LA CC398 isolates [2, 3].
The concomitant presence of this prophage in non-LA CC398
isolates and in non-LA CC9 isolates raises questions about the
contribution of horizontal transfer to the virulence of these iso-
lates, which were initially identiﬁed as strict animal pathogens.
The simultaneous emergence of invasive infections due to
CC398 and CC9 in humans without exposure to animals sug-
gests a rapid epidemiologic change in these S. aureus lineages
originally clearly associated with livestock. CC9 isolates have
been isolated from food items in the Netherlands and Germany
[18, 19], so the potential role of food products manufactured
from livestock and the route of transmission to patients without
animal exposure should be investigated in more detail.
Unlike CC398 isolates that lack several clinically important
S. aureus–associated virulence factors [20], the BSI CC9 iso-
lates studied here were similar to virulent S. aureus strains,
with many virulence genes. Concordant with previous obser-
vations [14,15], this strongly suggests that non-LA CC9 iso-
lates have a considerable virulence potential, even greater than
that of non-LA CC398 strains, given the contents of their re-
spective genomes. In addition, a CC9 isolate bearing the mul-
tidrug resistance gene cfr has been recently described [5],
suggesting that this clone can easily acquire genetic resistance
determinants by horizontal transfer.
Our data highlight the beneﬁts of an active surveillance
strategy for the early detection of new clones responsible for
invasive infections in humans that are adapted to both their
host and the hospital setting. In addition, given the speciﬁc
features of the genomic content of the non-LA CC9 isolates
described here, these ﬁndings indicate that there is a need for
active surveys to study and control the spread of this CC9
clone in humans.
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